Seikagaku Corporation (4548) Press Release
Seikagaku Announces Receipt of a Complete Response Letter Concerning the Biologics License Application in the U.S. for SI-6603
Earlier from Seikagaku
- [Summary] Consolidated Financial Results for the Three Months Ended June 30, 2026 (Under Japanese GAAP)
- Notice of Completion of Payment for Disposal of Treasury Shares as Restricted Stock Compensation
- Notice Concerning Disposal of Treasury Shares as Restricted Stock Compensation
- Seikagaku: Convocation Notice of the 80th Ordinary General Meeting of Shareholders